Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 4 | 2020 | 15 | 0.550 |
Why?
|
| Osteoarthritis | 2 | 2021 | 90 | 0.280 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 16 | 0.270 |
Why?
|
| Circadian Clocks | 1 | 2022 | 8 | 0.190 |
Why?
|
| Osteogenesis | 1 | 2022 | 69 | 0.180 |
Why?
|
| Male | 7 | 2022 | 1860 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 3 | 0.180 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 52 | 0.180 |
Why?
|
| Reoperation | 1 | 2021 | 37 | 0.170 |
Why?
|
| Bone Density | 1 | 2021 | 79 | 0.170 |
Why?
|
| Inflammation | 1 | 2020 | 31 | 0.160 |
Why?
|
| Osteolysis | 1 | 2020 | 29 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 26 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 59 | 0.160 |
Why?
|
| HIV Infections | 2 | 2017 | 103 | 0.150 |
Why?
|
| Animals | 5 | 2022 | 1050 | 0.150 |
Why?
|
| Kidney | 1 | 2018 | 13 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2018 | 12 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 14 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 5 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2018 | 69 | 0.130 |
Why?
|
| Colon | 2 | 2017 | 7 | 0.130 |
Why?
|
| Analgesics | 1 | 2018 | 20 | 0.130 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 2 | 0.130 |
Why?
|
| Microbiota | 1 | 2017 | 5 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 4 | 0.130 |
Why?
|
| Intestines | 1 | 2017 | 3 | 0.130 |
Why?
|
| Colon, Sigmoid | 1 | 2017 | 3 | 0.130 |
Why?
|
| Arthralgia | 1 | 2018 | 25 | 0.130 |
Why?
|
| DNA | 1 | 2017 | 28 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 4 | 0.130 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 3 | 0.130 |
Why?
|
| Food Hypersensitivity | 1 | 2017 | 3 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2017 | 4 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 43 | 0.130 |
Why?
|
| Humans | 6 | 2022 | 2957 | 0.130 |
Why?
|
| HIV-1 | 1 | 2017 | 59 | 0.130 |
Why?
|
| Female | 5 | 2021 | 1724 | 0.120 |
Why?
|
| Aging | 1 | 2018 | 204 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2013 | 21 | 0.100 |
Why?
|
| Mice | 3 | 2022 | 343 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2013 | 65 | 0.100 |
Why?
|
| DNA, Viral | 2 | 2017 | 5 | 0.070 |
Why?
|
| Viral Load | 2 | 2017 | 14 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 24 | 0.070 |
Why?
|
| Cytokines | 2 | 2017 | 33 | 0.070 |
Why?
|
| Middle Aged | 2 | 2021 | 792 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 88 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2022 | 5 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 5 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2022 | 67 | 0.050 |
Why?
|
| Sweden | 1 | 2021 | 3 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2021 | 9 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 22 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 89 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2021 | 25 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2021 | 53 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2021 | 60 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 52 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 275 | 0.040 |
Why?
|
| Rats | 1 | 2020 | 234 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 567 | 0.040 |
Why?
|
| Aged | 1 | 2021 | 956 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 19 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2018 | 3 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 4 | 0.030 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 5 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 40 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2018 | 25 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 2 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 2 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 9 | 0.030 |
Why?
|
| Ileum | 1 | 2017 | 5 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 9 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 16 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 19 | 0.030 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2017 | 1 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 2 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2017 | 7 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 17 | 0.030 |
Why?
|
| South Africa | 1 | 2017 | 3 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 47 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 119 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 122 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 4 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2013 | 5 | 0.030 |
Why?
|
| Permeability | 1 | 2013 | 13 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2013 | 5 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 39 | 0.030 |
Why?
|
| Disease Progression | 1 | 2013 | 99 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 97 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 208 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 174 | 0.020 |
Why?
|
| Brain | 1 | 2013 | 202 | 0.020 |
Why?
|